Glenmark Pharmaceuticals Ltd 2025 IR
The report highlights Glenmark Pharmaceuticals Limited's transition to Glenmark 3.0, focusing on science-led innovation in oncology, dermatology, and respiratory therapies. In FY 2025, the company achieved consolidated revenues of INR 133,217 million and expanded its global footprint to over 80 countries. Key achievements include the launch of Ryaltris in 11 new markets and a landmark licensing agreement with AbbVie for the oncology asset ISB 2001. On the sustainability front, the company achieved water positivity across its India operations and attained zero waste to landfill at all Indian manufacturing sites ahead of schedule.
Company: Glenmark Pharmaceuticals Ltd
Sector: Health Care
Country: India
Year: 2025
Type: IR
Pages: 412
Glenmark Pharmaceuticals Ltd
Integrated Annual Report
The report highlights Glenmark Pharmaceuticals Limited's transition to Glenmark 3.0, focusing on science-led innovation in oncology, dermatology, and respiratory therapies. In FY 2025, the company achieved consolidated revenues of INR 133,217 million and expanded its global footprint to over 80 countries. Key achievements include the launch of Ryaltris in 11 new markets and a landmark licensing agreement with AbbVie for the oncology asset ISB 2001. On the sustainability front, the company achieved water positivity across its India operations and attained zero waste to landfill at all Indian manufacturing sites ahead of schedule.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2025
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees